38
Views
114
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Phosphorylation of the Carboxyl-Terminal Transactivation Domain of c-Fos by Extracellular Signal-Regulated Kinase Mediates the Transcriptional Activation of AP-1 and Cellular Transformation Induced by Platelet-Derived Growth Factor

, &
Pages 7030-7043 | Received 05 Feb 2003, Accepted 24 Jun 2003, Published online: 27 Mar 2023

REFERENCES

  • Abate, C., D. R. Marshak, and T. Curran. 1991. Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions. Oncogene 6: 2179–2185.
  • Abe, M. K., W. L. Kuo, M. B. Hershenson, and M. R. Rosner. 1999. Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth. Mol. Cell. Biol. 19: 1301–1312.
  • Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729–739.
  • Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072: 129–157.
  • Bannister, A. J., H. J. Brown, J. A. Sutherland, and T. Kouzarides. 1994. Phosphorylation of the c-Fos and c-Jun HOB1 motif stimulates its activation capacity. Nucleic Acids Res. 22: 5173–5176.
  • Barber, J. R., and I. M. Verma. 1987. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum. Mol. Cell. Biol. 7: 2201–2211.
  • Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S. S. Bhagwat, A. M. Manning, and D. W. Anderson. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98: 13681–13686.
  • Chen, R. H., C. Abate, and J. Blenis. 1993. Phosphorylation of the c-Fos transrepression domain by mitogen- activated protein kinase and 90-kDa ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 90: 10952–10956.
  • Chen, R. H., P. C. Juo, T. Curran, and J. Blenis. 1996. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12: 1493–1502.
  • Chiariello, M., M. J. Marinissen, and J. S. Gutkind. 2000. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol. Cell. Biol. 20: 1747–1758.
  • Cochran, B. H., J. Zullo, I. M. Verma, and C. D. Stiles. 1984. Expression of the c-fos gene and of a fos-related gene is stimulated by platelet-derived growth factor. Science 226: 1080–1082.
  • Coso, O. A., M. Chiariello, G. Kalinec, J. M. Kyriakis, J. Woodgett, and J. S. Gutkind. 1995. Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway. J. Biol. Chem. 270: 5620–5624.
  • Deng, T., and M. Karin. 1994. c-Fos transcriptional activity stimulated by h-Ras-activated protein kinase distinct from JNK and ERK. Nature 371: 171–175.
  • English, J. M., and M. H. Cobb. 2002. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23: 40–45.
  • Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, R. A. Copeland, R. L. Magolda, P. A. Scherle, and J. M. Trzaskos. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273: 18623–18632.
  • Franchimont, N., D. Durant, S. Rydziel, and E. Canalis. 1999. Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2. J. Biol. Chem. 274: 6783–6789.
  • Galang, C. K., C. J. Der, and C. A. Hauser. 1994. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene 9: 2913–2921.
  • Gazit, A., H. Igarashi, I. M. Chiu, A. Srinivasan, A. Yaniv, S. R. Tronick, K. C. Robbins, and S. A. Aaronson. 1984. Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell 39: 89–97.
  • Grover-Bardwick, A., E. Adamson, and D. Mercola. 1994. Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells. Carcinogenesis 15: 1667–1674.
  • Gupta, P., and R. Prywes. 2002. ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression. J. Biol. Chem. 277: 50550–50556.
  • Hill, C. S., and R. Treisman. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80: 199–211.
  • Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70: 375–387.
  • Jamal, S., and E. Ziff. 1990. Transactivation of c-fos and beta-actin genes by raf as a step in early response to transmembrane signals. Nature 344: 463–466.
  • Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483–16486.
  • Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240–246.
  • Kerr, L. D., J. T. Holt, and L. M. Matrisian. 1988. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242: 1424–1427.
  • Kovary, K., and R. Bravo. 1991. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11: 4466–4472.
  • Kruijer, W., J. A. Cooper, T. Hunter, and I. M. Verma. 1984. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 312: 711–716.
  • Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156–160.
  • Lamph, W. W., P. Wamsley, P. Sassone-Corsi, and I. M. Verma. 1988. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 334: 629–631.
  • Ledwith, B. J., S. Manam, A. R. Kraynak, W. W. Nichols, and M. O. Bradley. 1990. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene. Mol. Cell. Biol. 10: 1545–1555.
  • Lucibello, F. C., and R. Muller. 1991. Proto-oncogenes encoding transcriptional regulators: unravelling the mechanisms of oncogenic conversion. Crit. Rev. Oncog. 2: 259–276.
  • Marinissen, M. J., M. Chiariello, and J. S. Gutkind. 2001. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev. 15: 535–553.
  • Marinissen, M. J., M. Chiariello, M. Pallante, and J. S. Gutkind. 1999. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5. Mol. Cell. Biol. 19: 4289–4301.
  • Mercola, D., A. Rundell, J. Westwick, and S. A. Edwards. 1987. Antisense RNA to the c-fos gene: restoration of density-dependent growth arrest in a transformed cell line. Biochem. Biophys. Res. Commun. 147: 288–294.
  • Murphy, L. O., S. Smith, R. H. Chen, D. C. Fingar, and J. Blenis. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4: 556–564.
  • Okazaki, K., and N. Sagata. 1995. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14: 5048–5059.
  • Piechaczyk, M., and J. M. Blanchard. 1994. c-fos proto-oncogene regulation and function. Crit. Rev. Oncol. Hematol. 17: 93–131.
  • Rydziel, S., D. Durant, and E. Canalis. 2000. Platelet-derived growth factor induces collagenase 3 transcription in osteoblasts through the activator protein 1 complex. J. Cell. Physiol. 184: 326–333.
  • Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131–E136.
  • Shaulian, E., and M. Karin. 2001. AP-1 in cell proliferation and survival. Oncogene 20: 2390–2400.
  • Sutherland, J. A., A. Cook, A. J. Bannister, and T. Kouzarides. 1992. Conserved motifs in Fos and Jun define a new class of activation domain. Genes Dev. 6: 1810–1819.
  • Teramoto, H., P. Salem, K. C. Robbins, X. R. Bustelo, and J. S. Gutkind. 1997. Tyrosine phosphorylation of the vav proto-oncogene product links FcεRI to the Rac1-JNK pathway. J. Biol. Chem. 272: 10751–10755.
  • Tong, L., S. Pav, D. M. White, S. Rogers, K. M. Crane, C. L. Cywin, M. L. Brown, and C. A. Pargellis. 1997. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 4: 311–316.
  • Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8: 205–215.
  • Treisman, R. 1994. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4: 96–101.
  • Whitmarsh, A. J., and R. J. Davis. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74: 589–607.
  • Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403–407.
  • Wick, M., F. C. Lucibello, and R. Muller. 1992. Inhibition of Fos- and Ras-induced transformation by mutant Fos proteins with structural alterations in functionally different domains. Oncogene 7: 859–867.
  • Wisdon, R., and I. M. Verma. 1993. Transformation by Fos proteins requires a C-terminal transactivation domain. Mol. Cell. Biol. 13: 7429–7438.
  • Zhan, Y., S. Kim, H. Yasumoto, M. Namba, H. Miyazaki, and H. Iwao. 2002. Effects of dominant-negative c-Jun on platelet-derived growth factor-induced vascular smooth muscle cell proliferation. Arterioscler. Thromb. Vasc. Biol. 22: 82–88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.